Ensysce Biosciences Inc (ENSC)
0.55
-0.01
(-1.54%)
USD |
NASDAQ |
Apr 25, 16:00
0.55
0.00 (0.00%)
After-Hours: 20:00
Ensysce Biosciences Total Assets (Quarterly): 2.708M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.708M |
| September 30, 2023 | 3.219M |
| June 30, 2023 | 6.358M |
| March 31, 2023 | 3.915M |
| December 31, 2022 | 5.885M |
| September 30, 2022 | 8.290M |
| Date | Value |
|---|---|
| June 30, 2022 | 7.949M |
| March 31, 2022 | 12.37M |
| December 31, 2021 | 16.42M |
| September 30, 2021 | 9.718M |
| June 30, 2021 | 9.196M |
| December 31, 2020 | 0.3518M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.3518M
Minimum
Dec 2020
16.42M
Maximum
Dec 2021
7.198M
Average
7.153M
Median
Total Assets (Quarterly) Benchmarks
| Processa Pharmaceuticals Inc | 5.787M |
| Omeros Corp | 378.27M |
| Relmada Therapeutics Inc | 97.55M |
| NeuroBo Pharmaceuticals Inc | 22.78M |
| MAIA Biotechnology Inc | 7.567M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.359M |
| Shareholders Equity (Quarterly) | -0.3229M |